AGN 203818

DRUG4 trials

Sponsors

Allergan

Conditions

Cystitis, InterstitialDiabetic Neuropathy, PainfulFibromyalgiaIrritable Bowel Syndrome

Phase 2

Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

TerminatedNCT00380783

AllerganCystitis, Interstitial

Start: 2006-10-31End: 2007-03-31Updated: 2011-05-30

Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

CompletedNCT00381719

AllerganDiabetic Neuropathy, Painful

Start: 2006-10-31End: 2007-11-30Updated: 2008-01-07

Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain

TerminatedNCT00441766

AllerganIrritable Bowel Syndrome

Start: 2007-03-31End: 2008-02-29Updated: 2012-01-20

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

TerminatedNCT00445705

AllerganFibromyalgia

Start: 2007-03-31End: 2008-01-31Updated: 2015-09-07